logo
Медицинский вестник
Северного Кавказа
Научно-практический журнал
Зарегистрирован в Федеральной службе
по надзору за соблюдением законодательства
в сфере массовых коммуникаций
и охране культурного наследия
ПИ №ФС77-26521 от 7 декабря 2006 года
ISSN 2073-8137
rus
русский
eng
english

Поиск по сайту




Адрес редакции
355017, Ставрополь, улица Мира, 310.

Телефоны
(8652) 35-25-11, 35-32-29.

E-mail
medvestnik@stgmu.ru

Рейтинг@Mail.ru

Современная парадигма микроскопического колита

[Обзоры]
Корой Павел Владимирович; Ягода Александр Валентинович;

Освещено современное состояние проблемы относительно редко пока ещё диагностируемого заболевания – микроскопического колита, включая вопросы эпидемиологии, патогенеза, клиники, новых диагностических подходов и терапевтических стратегий.

Скачать

Список литературы:
1. Abboud, R. Symptomatic overlap between microscopic colitis and irritable bowel syndrome: a prospective study / R. Abboud, D. S. Pardi, W. J. Tremaine [et al.] // Inflamm. Bowel. Dis. – 2013. – Vol. 19, № 3. – Р. 550–553.
2. Aust, D. Topographical distribution of collagenous colitis–a pooled histological analysis of 2 European prospective multicenter trials / D. Aust, A. Münch, M. Olesen [et al.] // Gastroenterology. – 2013. – Vol. 144. – Р. S. 421.
3. Bjornbak, C. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups / C. Bjornbak, P. J. Engel, P. L. Nielsen, L. K. Munck // Aliment. Pharmacol. Ther. – 2011. – Vol. 34, № 10. – Р. 1225–1234.
4. Bonderup, O. K. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial / O. K. Bonderup, J. B. Hansen, P. S. Teglbjaerg [et al.] // Gut. – 2009. – Vol. 58. – Р. 68–72.
5. Brown, W. R. Microscopic colitis. A review / W. R. Brown, S. Tayal // J. Dig. Dis. – 2013. – Vol. 14. – Р. 277–281.
6. Calabrese, C. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial / C. Calabrese, A. Fabbri, A. Areni [et al.] // J. Gastroenterol. Hepatol. – 2007. – Vol. 22. – Р. 809–814.
7. Chande, N. Interventions for treating microscopic colitis: A Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials / N. Chande, J. K. MacDonald, J. W. McDonald // Am. J. Gastroenterol. – 2009. –Vol. 104. – Р. 235–241.
8. Corti-Hoekstra, L. R. Report from the Falk workshop on microscopic colitis: Creating awareness for an underappreciated disease / L. R. Corti-Hoekstra, J. M. H. van den Brande, M. P. Peppelenbosch // Gastroenterology. – 2012. – Vol. 143. – Р. 1–3.
9. Couto, G. Unique endoscopy findings in collagenous colitis / G. Couto, M. Bispo, P. Barreiro [et al.] // Gastrointest. Endosc. – 2009. – Vol. 69. – Р. 1186–1188.
10. Esteve, M. Efficacy of anti-TNF therapies in refractory severe microscopic colitis / M. Esteve, U. Mahadevan, E. Sainz [et al.] // J. Crohns. Colitis. – 2011. – Vol. 5. – Р. 612–618.
11. Fernandez-Banares, F. Drug consumption and the risk of microscopic colitis / F. Fernandez-Banares, M. Esteve, J. C. Espinos [et al.] // Am. J. Gastroenterol. – 2007. – Vol. 102, № 2. – Р. 324–330.
12. Fernandez-Banares, F. Epidemiological risk factors in microscopic colitis: а prospective case-control study / F. Fernandez-Banares, M. R. deSousa, A. Salas [et al.] // Inflamm. Bowel. Dis. – 2013. – Vol. 19, № 2. – Р. 411–417.
13. Fernandez-Banares, F. Impact of current smoking on the clinical course of microscopic colitis / F. Fernandez- Banares, M. R. de Sousa, A. Salas [et al.] // Inflamm. Bowel. Dis. – 2013. – Vol. 19, № 7. – Р. 1470–1476.
14. Gentile, N. M. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study / N. M. Gentile, A. Abdalla, S. Khanna [et al.] // Am. J. Gastroenterol. – 2013. – Vol. 108, № 2. – Р. 256–259.
15. Gentile, N. M. The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study / N. M. Gentile, S. Khanna, E. V. Jr. Loftus [et al.] // Clin. Gastroenterol. Hepatol. – 2014. – Vol. 12, № 5. – Р. 838–842.
16. Griga, T. Collagenous colitis: implications for the role of vascular endothelial growth factor in repair mechanisms / T. Griga, A. Tromm, W. Schmiegel [et al.] // Eur. J. Gastroenterol. Hepatol. – 2004. – Vol. 16, № 4. – Р. 397–402.
17. Hjortswang, H. Defining clinical criteria for clinical remission and disease activity in collagenous colitis / H. Hjortswang, C. Tysk, J. Bohr [et al.] // Inflamm. Bowel Dis. – 2009. – Vol. 15. – Р. 1875–1881.
18. Hjortswang, H. Health-related quality of life is impaired in active collagenous colitis / H. Hjortswang, C. Tysk, J. Bohr, C. Benoni [et al.] // Dig. Liver. Dis. – 2011. – Vol. 43, № 2. – Р. 102–109.
19. Holstein, A. Autoantibody profiles in microscopic colitis / A. Holstein, J. Burmeister, A. Plaschke [et al.] // J. Gastroenterol. Hepatol. – 2006. – Vol. 21. – Р. 1016–1020.
20. Ianiro, G. Microscopic colitis / G. Ianiro, G. Cammarota, L. Valerio [et al.] // World J. Gastroenterol. – 2012. – Vol. 18, № 43. – Р. 6206–6215.
21. Keszthelyi, D. Is microscopic colitis a drug-induced disease? / D. Keszthelyi, J. Penders, A. A. Masclee, M. Pierik // J. Clin. Gastroenterol. – 2012. – Vol. 46, № 10. – Р. 811–822.
22. Koskela, R. M. Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis / R. M. Koskela, T. J. Karttunen, S. E. Niemela [et al.] // Eur. J. Gastroenterol. Hepatol. – 2008. – Vol. 20. – Р. 276–282.
23. Koulaouzidis, A. Distinct colonoscopy findings of microscopic colitis: not so microscopic after all? / A. Koulaouzidis, A. A. Saeed // World J. Gastroenterol. – 2011. – Vol. 17. – Р. 4157–4165.
24. Kumawat, A. K. Microscopic colitis patients have increased proportions of Ki67(+) proliferating and CD45RO(+) active/memory CD8(+) and CD4(+)8(+) mucosal T cells / A. K. Kumawat, H. Strid, K. Elgbratt [et al.] // J. Crohns. Colitis. – 2013. – Vol. 7, № 9. – Р. 694–705.
25. LaSala, P. R. Seasonal pattern of onset in lymphocytic colitis / P. R. LaSala, A. B. Chodosh, J. A. Vecchio [et al.] // J. Clin. Gastroenterol. – 2005. – Vol. 39. – Р. 891–893.
26. Limsui, D. Symptomatic overlap between irritable bowel syndrome and microscopic colitis / D. Limsui, D. S. Pardi, M. Camilleri [et al.] // Inflamm. Bowel. Dis. – 2007. – Vol. 13, № 2. – Р. 175–181.
27. Madisch, A. Allelic variation of the matrix metalloproteinase- 9 gene is associated with collagenous colitis / A. Madisch, S. Hellmig, S. Schreiber [et al.] // Inflamm. Bowel. Dis. – 2011. – Vol. 17, № 11. – Р. 2295–2298.
28. Madisch, A. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebocontrolled, multicenter trial / A. Madisch, S. Miehlke, O. Eichele [et al.] // Int. J. Colorectal. Dis. – 2007. – Vol. 22. – Р. 1445–1451.
29. Mahajan, D. Lymphocytic colitis and collagenous colitis: a review of clinicopathologic features and immunologic abnormalities / D. Mahajan, J. R. Goldblum, S. Y. Xiao [et al.] // Adv. Anat. Pathol. – 2012. – Vol. 19, № 1. – Р. 28–38.
30. Miehlke, S. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebocontrolled study / S. Miehlke, A. Madisch, D. Karimi [et al.] // Gastroenterology. – 2009. – Vol. 136. – Р. 2092–2100.
31. Miehlke, S. Double-blind, double-dummy, randomized, placebo-controlled, multicenter trial of Budesonide and mesalamine in collagenous colitis / S. Miehlke, A. Madisch, L. Kupcinskas [et al.] // Gastroenterology. – 2012. – Vol. 142, Suppl. 1. – Р. S. 211.
32. Münch, A. Adalimumab in budesonide and methotrexate refractory collagenous colitis / A. Münch, S. Ignatova, M. Ström // Scand. J. Gastroenterol. – 2012. – Vol. 47. – Р. 59–63.
33. Münch, A. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis / A. Münch, F. Fernandez-Banares, L. K. Munck // Aliment. Pharmacol. Ther. – 2013. – Vol. 37. – Р. 795–798.
34. Münch, A. Dynamics of mucosal permeability and inflammation in collagenous colitis before, during, and after loop ileostomy / A. Münch, J. D. Soderholm, C. Wallon [et al.] // Gut. – 2005. – Vol. 54, № 8. – Р. 1126–1128.
35. Münch, A. Lack of effect of methotrexate in budesoniderefractory collagenous colitis / A. Münch, J. Bohr, L. Vigren [et al.] // Clin. Exp. Gastroenterol. – 2013. – Vol. 6. – Р. 149–152.
36. Münch, A. Microscopic colitis: clinical and pathologic perspectives / A. Münch, C. Langner // Clin. Gastroenterol. Hepatol. – 2015. – Vol. 13. – Р. 228–236.
37. Münch, A. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group / A. Münch, D. Aust, J. Bohr [et al.] // J. Crohns. Colitis. – 2012. – Vol. 6, № 9. – Р. 932–945.
38. Nguyen, G. C. American Gastroenterological Association institute guideline on the medical management of microscopic colitis / G. C. Nguyen, W. E. Smalley, S. S. Vege, A. Carrasco-Labra // Gastroenterology. – 2016. – Vol. 150, № 1. – P. 242–246.
39. Ohlsson, B. New insights and challenges in microscopic colitis / B. Ohlsson // Ther. Adv. Gastroenterol. – 2015. – Vol. 8, № 1. – P. 37–47.
40. Olesen, M. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993–1998 / M. Olesen, S. Eriksson, J. Bohr [et al.] // Gut. – 2004. – Vol. 53, № 3. – Р. 346–350.
41. Pardi, D. S. A randomized, double-blind, placebocontrolled trial of budesonide for the treatment of active lymphocytic colitis / D. S. Pardi, E. V. Loftus, W. J. Tremaine, W. J. Sandborn // Gastroenterology. – 2009. – Vol. 136, № 5, Suppl. 1. – Р. A519–520.
42. Pardi, D. S. After budesonide, what next for collagenous colitis? / D. S. Pardi // Gut. – 2009. – Vol. 58. – Р. 3–4.
43. Pardi, D. S. American Gastroenterological Association institute technical review on the medical management of microscopic colitis / D. S. Pardi, W. J. Tremaine, A. Carrasco-Labra // Gastroenterology. – 2016. – Vol. 150, № 1. – P. 247–274.
44. Pardi, D. S. Microscopic сolitis / D. S. Pardi // Clin. Geriatr. Med. – 2014. – Vol. 30. – Р. 55–65.
45. Pardi, D. S. Microscopic colitis / D. S. Pardi, C. P. Kelly //Gastroenterology. – 2011. – Vol. 140. – Р. 1155–1165.
46. Pardi, D. S. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota / D. S. Pardi, E. V. Loftus, T. C. Smyrk [et al.] // Gut. – 2007. – Vol. 56. – Р. 504–508.
47. Pola, S. Successful use of infliximab in the treatment of corticosteroid dependent collagenous colitis / S. Pola, M. Fahmy, E. Evans [et al.] // Am. J. Gastroenterol. – 2013. – Vol. 108, № 5. – Р. 857–858.
48. Riddell, J. Collagenous colitis: oral low-dose methotrexate for patients with difficult symptoms: longterm outcomes / J. Riddell, L. Hillman, L. Chiragakis, A. Clarke // J. Gastroenterol. Hepatol. – 2007. – Vol. 22. – Р. 1589–1593.
49. Tagkalidis, P. P. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile / P. P. Tagkalidis, P. R. Gibson, P. S. Bhathal // J. Clin. Pathol. – 2007. – Vol. 60. – Р. 382–387.
50. Tysk, C. Diagnosis and management of microscopic colitis / C. Tysk, J. Bohr, N. Nyhlin [et al.] // World J. Gastroenterol. – 2008. – Vol. 14, № 48. – Р. 7280–7288.
51. Tysk, C. Recent advances in diagnosis and treatment of microscopic colitis / C. Tysk, A. Wickbom, N. Nyhlin [et al.] // Ann. Gastroenterol. – 2011. – Vol. 24. – Р. 1–10.
52. Vigren, L. Celiac disease and other autoimmune diseases in patients with collagenous colitis / L. Vigren, C. Tysk, M. Strom [et al.] // Scand. J. Gastroenterol. – 2013. – Vol. 48, № 8. – Р. 944–950.
53. Vigren, L. Is smoking a risk factor for collagenous colitis? / L. Vigren, K. Sjoberg, C. Benoni [et al.] // Scand. J. Gastroenterol. – 2011. – Vol. 46, № 11. – Р. 1334–1339.
54. Wagner, M. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study / M. Wagner, C. G. Peterson, I. Stolt [et al.] // Scand. J. Gastroenterol. – 2011. – Vol. 46, № 7-8. – Р. 849–854.
55. Wickbom, A. Stable incidence of collagenous colitis and lymphocytic colitis in Orebro, Sweden, 1999–2008: a continuous epidemiologic study / A. Wickbom, J. Bohr, S. Eriksson, C. Tysk // Inflamm. Bowel. Dis. – 2013. – Vol. 19, № 11. – Р. 2387–2393.
56. Wildt, S. Metabolic and inflammatory faecal markers in collagenous colitis / S. Wildt, I. Nordgaard-Lassen, F. Bendtsen, J. J. Rumessen // Eur. J. Gastroenterol. Hepatol. – 2007. – Vol. 19. – Р. 567–574.
57. Wildt, S. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis / S. Wildt, L. K. Munck, L. Vinter-Jensen [et al.] // Inflamm. Bowel Dis. – 2006. – Vol. 12. – Р. 395–401.
58. Williams, J. J. Microscopic colitis-defining incidence rates and risk factors: a population-based study / J. J. Williams, G. G. Kaplan, S. Makhija [et al.] // Clin. Gastroenterol. Hepatol. – 2008. – Vol. 6, № 1. – Р. 35–40.
59. Yen, E. F. Decreased colorectal cancer and adenoma risk in patients with microscopic colitis / E. F. Yen, B. Pokhrel, L. K. Bianchi [et al.] // Dig. Dis. Sci. – 2011. – Vol. 57, № 1. – Р. 161–169.
60. Yen, E. F. Review article: microscopic colitis – lymphocytic, collagenous and «mast cell» colitis / E. F. Yen, D. S. Pardi // Aliment. Pharmacol. Ther. – 2011. – Vol. 34. – Р. 21–32.

Ключевые слова: микроскопический колит, лимфоцитарный колит, коллагеновый колит, диарея, лечение, будесонид


Учредители:
Ставропольская государственная медицинская академия
Государственный научно-исследовательский институт курортологии
Пятигорская государственная фармацевтическая академия